October 7, 2007
Diabetes.....
Analysis of:
Burden of diabetes care rivals disease complications | www.reuters.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Implications: I know that Pfizer finally came out with the inhaled insulin after many years of hype. Unfortunately its launch and the product has been a flop, primarily because of the size if the inhaler. It is large and looks like a can of tennis balls. It is difficult for the patient to understand the dosing and usage as well. However, it was a good try for a first generation product. I think our country is getting better at managing diabetes with the new onset of drugs available.
Analysis: Soon there will be another inhaled insulin product in a smaller, easier to use inhaler.
Analysis: Soon there will be another inhaled insulin product in a smaller, easier to use inhaler.
Report a Concern
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Painkiller Risk Found for Heart Patients
www.nytimes.com
FDA Asks if Pain Pill Is Tamper-Proof
online.wsj.com
Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
www.pipelinereview.com
Hospitals See Drop in Paying Patients
www.nytimes.com
Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
www.fiercebiotech.com
Is Celebrex Next ?
November 18, 2008
Will contact lens solutions cost more to ship and store?
November 13, 2008
Economy's impact on healthcare facilities
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
A closer look
November 11, 2008

